MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer

SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--MyoKardia, Inc., a company focused on developing innovative therapeutics to treat genetic cardiovascular disease, today announced the appointment of Jonathan C. Fox, M.D., Ph.D., as Chief... Biopharmaceuticals, Cardiology, PersonnelMyoKardia, Jonathan C. Fox, cardiomyopathy, genetic cardiovascular disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news